Education
About Us
Working with TipRanks
Follow Us
Martin A. Lehr Insider Profile
4 Followers
Martin A. Lehr, CEO, Director at Context Therapeutics, holds 1.08M shares in Context Therapeutics (Ticker: CNTX). Most recently, Martin A. Lehr Bought 100,000 shares of Context Therapeutics on Jun 10, 2025 for an estimated value of $70.00K.
Martin A. Lehr Context Therapeutics (CNTX)CEO, Director
Context Therapeutics (CNTX)
CEO, Director
Ranked #9,382 out of 106,487 Corporate Insiders
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+50.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Martin A. Lehr holds in companies
Most Profitable Insider Trade
The most profitable trade made by Martin A. Lehr
Martin A. Lehr's Trading History
List of latest transactions for each holding click on a transaction to see Martin A. Lehr's performance on stock
You May Also Like
Martin A. Lehr insider profile FAQ
What is the percentage of profitable transactions made by Martin A. Lehr?
The percentage of profitable transactions made by Martin A. Lehr is 40%.
What is the average return per transaction made by Martin A. Lehr?
The average return per transaction made by Martin A. Lehr is 50.40%.
What stocks does Martin A. Lehr hold?
Martin A. Lehr holds: CNTX stocks.
What was Martin A. Lehr’s latest transaction?
Martin A. Lehr latest transaction was an Informative Buy of $70.00K.
What was Martin A. Lehr's most profitable transaction?
Martin A. Lehr’s most profitable transaction was an Informative Buy of CNTX stock on June 10, 2025. The return on the trade was 402.90%.
What is Martin A. Lehr's role in Context Therapeutics?
Martin A. Lehr's role in Context Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.